Keep it real
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Calling the 41 patient size puny is a pure personal opinion.
source:
Phase II clinical trials provide more detailed information about the safety of the treatment, in addition to evaluating how well it works. These clinical trials focus on finding out whether the new treatment works for a specific cancer, which may be measured by a decrease in tumor size or through blood tests. Phase II clinical trials take about two years to complete and usually involve about 20 to 40 people. Sometimes phase II clinical trials will assign patients to several possible treatments. This is known as a randomized phase II trial and may include up to several hundred patients. The new treatment needs to show it is likely to work and is safe when compared to the standard treatment for it to be tested in phase III clinical trials.
I may not remember to much from my math courses but what I do remember is that 6 months is half a year.
Question was define real progress
Oh there have lots of things cleared up over the weekend, thanks!
Please define real progress
Is that like when they start a p2 combination trial?
Or when they are doing a quick trial to see if it is worth lather down the road to expand the pipeline in head&neck cancer?
Savvy investors smell a shorting scam from a mile away.
I hope it works out for you 'cause you are taking a hell of a risk. Then again you could make a hell of a profit. Time will tell.
Why is the world round?
Why are bananas not straight?
The pps tested the 50dma because mm's felt they could given current general market situation and then it just whiplashed away from it.
Depends which personality is in control?
Life is so much nicer when one can be for something rather then against something.
So you put a bet on ONCS?
As the dump part is already taken, how about I take the pump part?
I guess nothing would ever count for the FDA as they must by now be fully aware what a scam Oncosec is.
Are they keeping track of iHub? Plenty of scientific news on here to help them decide!
I know, happy for you!
Do not get me started on AF ;)
One thing for sure, when he start bashing AVXL you know you are on to something good!
Lucky you, my order at .98 did not get filled :(
And therefore by logical deduction this will happen to all OTC stocks
You found your buddy, happy for you Josh!
And I presume you lost a lot of money on it?
you are entitled to your opinion, but so far there is not a single indication. Rather the opposite as the initial plan was to release the interim results in September but that was advanced rather then delayed.
Believe me when I tell you that the CEO wants the uplisting sooner then later cause it is another milestone that entitles him to another million shares.
Look for this early in the next year when the full results of p2a are released.
Oh yeah, epilepsy trial to start very soon as well,
Sorry but take your scaring tactics somewhere else please.
I do not define long term as the evolution of the pps in the next 3 months but rather in the next 3-5 years.
But we do know that in the next 12 weeks max, we will have full results of the p2 a-fase and possibly interim results of the p2 b-fase. If good, that will propel the stock further.
Just remember that you will inherit her profits :)
No clear catalyst on the horizon???
LOL, thanks for a good joke!
If you are referring to the big crowd that was here some months ago, they moved on to their next pick.
Luckiliy the really good ones, with great knowledge have remained and I enjoy their postings a lot.
Let's hope it runs and that the interim data will be good.
If it is not then this will be giant implosion.
Excellent summary Wait
And may I add that all those forces are present here on this forum.
Disregard Zacks. Their rating system is based on estimate earnings. As we are biotech with no earnings, it's a worthless system.
From the FAQ deletions and restorations'
This one lady never uses "IMO" (In My Opinion) – she states everything as if it's fact and it's not!
It is understood that all posts on the site are to be considered opinions. They do not need to indicate this in their posts.
Great to know that Oncosec has competent scientist too. That is a very good reason to track this company.
Nice find!
Exactly, increase exposure ;)
Makes sense for him to do the investor conference, thats why they hired him: increase exposure and attract money. His track record is great in both.
Oncosec pass the 2nd criterium as it is in pursut of cancer therapies but it seems you do not believe they have competent staff?
So Oncosec does not have competent scientist? Sure we know they have nice guys
So Oncosec does not have competent scientist? Then why track it?
Sure, just like Oncosec
No I do not. But I would say if we do then we not we are max 4 weeks away from good news.
Can I borrow your crystal ball please?